Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes

Diabetic nephropathy (DN) is now the single commonest cause of end-stage renal disease (ESRD) worldwide and one of the main causes of death in diabetic patients. It is also acknowledged as an independent risk factor for cardiovascular disease (CVD). Since sitagliptin was approved, many studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Mega, Cristina, Teixeira-de-Lemos, Edite, Fernandes, Rosa, Reis, Flávio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643039/
https://www.ncbi.nlm.nih.gov/pubmed/29098166
http://dx.doi.org/10.1155/2017/5164292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643039/
https://www.ncbi.nlm.nih.gov/pubmed/29098166
http://dx.doi.org/10.1155/2017/5164292

Ejemplares similares